Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nab-paclitaxel and Gemcitabine in Metastatic Breast Cancer
NCT00110084Phase 2Completed
- Sponsor
- Mayo Clinic
- Start
- Aug 2005
- Primary completion
- May 2010
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of nab-paclitaxel in breast cancer, sponsored by Mayo Clinic. Primary endpoints: Proportion of Patients With Confirmed Responses and Incidence and Severity of Observed Toxic Effects. Started Aug 2005; status: completed.
02
Drugs
nab-paclitaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00110084.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00110084.